Skip to main content
OpenTrials
Completed

NCT Number: NCT00622583

International Hernia Mesh Registry

This is an open-label, multi-center, long-term, prospective hernia mesh registry. A minimum of 4,800 hernia patients will be enrolled from approximately 60 active sites globally

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Queen Elizabeth Hospital, Woodville, South Australia, Australia

Loading trial locations.

About this study

Patients will be followed for 2-years post-implantation, in a post-market setting to help identify best practices leading to lower recurrence rates and decreases in chronic pain, associated with the hernia repair procedure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients must satisfy the following criteria before entering the registry:

  • Provide written informed consent prior to surgery;
  • Male or female patients that are > 18 years of age;
  • Be literate and able to understand a language available in the Registry Patient Questionnaires;
  • Scheduled to receive a surgically implanted ETHICON synthetic mesh using any fixation method or a non-ETHICON synthetic mesh which must be fixated with SECURESTRAP® or SECURESTRAP® Open for repair of a hernia defect;
  • Agree to provide long-term, outcomes data to Quintiles Outcome;
  • Agree to provide contact information;
  • Two or more pieces of the same mesh product sewn together will be considered as one mesh, and is therefore allowed in this registry

Exclusion criteria

Patients who meet any of the following criteria will be excluded from participating in the registry:

  • Patients that are <18 years of age;
  • Patients who have been entered into the registry previously;
  • Employees of the investigator or registry center with direct involvement in the proposed registry or other studies under the direction of that investigator or registry center and employees of ETHICON;
  • Patients suffering from and currently receiving medication for chronic pain (defined as suffering pain for greater than 3 months);
  • Patients known to be suffering from pre-existing chronic depression;
  • Patients currently known or suspected to abuse drugs or alcohol;
  • Patients suffering from a terminal illness (e.g. cancer);
  • Patients requiring multiple hernia repairs (including bilateral inguinal/femoral);
  • Patients requiring any other (concomitant) surgical procedure;
  • Patients suffering from an ongoing infection, sepsis, contaminated mesh or fistulas;
  • Patients who require hiatal, paraesophageal or diaphragmatic hernia repair;
  • Patients requiring two different types of meshes;
  • Patients requiring two or more meshes not sewn together
  • Patients scheduled to receive a surgically implanted biologic mesh product for repair of a hernia defect

Treatment and study plan

Primary outcomes

  1. Recurrence of the hernia

    Time frame: 1 month, 6-months, 12 months, 2 years

  2. Pain assessment scores by patients for the duration of the registry (Acute pain and Chronic pain)

    Time frame: 1 month, 6-months, 12 months, 2 years

Secondary outcomes

  1. Assessment of post-operative complications/safety

    Time frame: At the time of surgery

  2. Assessment of procedure time

    Time frame: At the time of surgery

Sponsors and collaborators

Lead sponsor

Ethicon, Inc.

Industry

Registry information

Official study title

A Two-Year Follow-up, Post-Implantation, Multi-center, International Hernia Mesh Registry

Acronym: IHMR

Important dates

Study start
2007
Primary completion
2019
Study completion
2021
First posted
Feb 25, 2008
Registry last updated
Jun 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.